Patents Assigned to DENDROGENIX
  • COMPOUNDS DERIVED FROM STEROLS FOR THE TREATMENT OF A DISEASE ASSOCIATED WITH A MITOCHONDRIAL DEFICIT
    Publication number: 20260183311
    Abstract: A sterol-based compound of formula (I) for its use in preventing, ameliorating and/or treating a mitochondrial deficiency-related pathology chosen from the group consisting of autism, spinal cord injury, multiple sclerosis, epilepsy, migraine, alcohol-related mental pathologies, ataxia, neuropathies, smoking-related cerebral and pulmonary disorders, MERRF syndrome and NARP syndrome. A pharmaceutical composition comprising at least one compound of formula (I).
    Type: Application
    Filed: June 14, 2023
    Publication date: July 2, 2026
    Applicant: DENDROGENIX
    Inventors: Stéphane SILVENTE, Nicolas CARON, Arnaud RIVES, Quentin MARLIER, Hélène MICHAUX, Dario MOSCA, Maxime GILSOUL
  • PRODRUG OF 5a-HYDROXY-6ß-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3ß-OL AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME FOR USE IN THE TREATMENT OF CANCER
    Publication number: 20240002429
    Abstract: The invention relates to a novel compound of general formula (I): and/or a pharmaceutically acceptable salt of a compound of this kind, a pharmaceutical composition comprising at least said compound, for use thereof as a drug for causing regression of a mammalian cancerous tumor.
    Type: Application
    Filed: December 3, 2021
    Publication date: January 4, 2024
    Applicant: DENDROGENIX
    Inventors: Stéphane SILVENTE, Quentin MARLIER, Arnaud RIVES, Nicolas CARON, Dario MOSCA, Hélène MICHAUX
  • 5ALPHA-HYDROXY-6BETA-[2-(1-H-IMIDAZOL-4-YL)-ETHYLAMINO]-CHOLESTAN-3BETA-OL ANALOGUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME FOR USE IN THE TREATMENT OF CANCER
    Publication number: 20230391817
    Abstract: The invention relates to a novel compound of general formula (I): and/or a pharmaceutically acceptable salt of such a compound, to a pharmaceutical composition comprising at least said compound, for its use as a medicament for shrinking a mammalian cancerous tumor.
    Type: Application
    Filed: October 28, 2021
    Publication date: December 7, 2023
    Applicant: DENDROGENIX
    Inventors: Stéphane SILVENTE, Quentin MARLIER, Arnaud RIVES, Nicolas CARON, Dario MOSCA, Hélène MICHAUX